GFACX
Price
$74.49
Change
+$0.29 (+0.39%)
Updated
Sep 26 closing price
Net Assets
335.66B
PNOPX
Price
$129.63
Change
+$0.48 (+0.37%)
Updated
Sep 26 closing price
Net Assets
6.49B
Interact to see
Advertisement

GFACX vs PNOPX

Header iconGFACX vs PNOPX Comparison
Open Charts GFACX vs PNOPXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.49
Change+$0.29 (+0.39%)
VolumeN/A
Net Assets335.66B
Putnam Sustainable Leaders A
Price$129.63
Change+$0.48 (+0.37%)
VolumeN/A
Net Assets6.49B
GFACX vs PNOPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. PNOPX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and PNOPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 336B vs. PNOPX (6.49B). PNOPX pays higher dividends than GFACX: PNOPX (0.46) vs GFACX (0.00). GFACX was incepted earlier than PNOPX: GFACX (25 years) vs PNOPX (35 years). GFACX (1.36) is less costly to investors than PNOPX (0.87). GFACX is a more actively managed with annual turnover of: 25.00 vs. PNOPX (22.00). PNOPX has a lower initial minimum investment than GFACX: PNOPX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.17 vs. PNOPX (-3.78). GFACX return over 5 years is better than : 37.51 vs. PNOPX (22.30).
GFACXPNOPXGFACX / PNOPX
Total Expense Ratio1.360.87156%
Annual Report Gross Expense Ratio1.360.87156%
Fund Existence25 years35 years-
Gain YTD16.3745.489298%
Front LoadN/A6%-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets336B6.49B5,176%
Annual Yield % from dividends0.000.46-
Returns for 1 year10.17-3.78-269%
Returns for 3 years64.8541.90155%
Returns for 5 years37.5122.30168%
Returns for 10 years93.0388.99105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.900.06
+2.11%
CytomX Therapeutics
SOLV71.370.91
+1.29%
Solventum Corp
EPAC40.200.49
+1.23%
Enerpac Tool Group Corp
BAOS3.300.04
+1.23%
Baosheng Media Group Holdings Limited
YTRA1.43N/A
+0.35%
Yatra Online